Cargando…

Organ-specific considerations for marginal zone lymphomas in Korea, based on Consortium for Improving Survival of Lymphoma (CISL) and Korean clinical studies

Detalles Bibliográficos
Autores principales:	Oh, Sung Yong, Suh, Cheolwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439296/ https://www.ncbi.nlm.nih.gov/pubmed/30956956 http://dx.doi.org/10.5045/br.2019.54.1.4

Ejemplares similares

The Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective
por: Suh, Cheolwon, et al.
Publicado: (2017)

Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study
por: Lee, Seul, et al.
Publicado: (2015)

Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
por: Oh, Sung Yong, et al.
Publicado: (2019)

Consortium for Improving Survival of Lymphoma (CISL): a model of multicenter collaboration for lymphoma studies in Korea
por: Kim, Seok Jin
Publicado: (2015)

Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)
por: Kim, Seok Jin, et al.
Publicado: (2011)

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study
por: Yhim, Ho-Young, et al.
Publicado: (2010)

Non-gastric Marginal Zone B-cell Lymphoma in Korea: Clinical Features, Treatment, and Prognostic Factors
por: Oh, Sung Yong, et al.
Publicado: (2010)

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
por: Kim, Yu Ri, et al.
Publicado: (2012)

Review of the clinical research conducted by the Consortium for Improving Survival of Lymphoma of the Korean Society of Hematology Lymphoma Working Party
por: Suh, Cheolwon, et al.
Publicado: (2013)

Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study
por: Kim, Yu Ri, et al.
Publicado: (2023)

Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09)
por: Yoon, Dok Hyun, et al.
Publicado: (2017)

Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma
por: Kang, Byung Woog, et al.
Publicado: (2014)

Dermatological Considerations in the Diagnosis and Treatment of Marginal Zone Lymphomas
por: Ronchi, Andrea, et al.
Publicado: (2021)

Marginal zone lymphoma
por: Kimby, Eva
Publicado: (2018)

Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial
por: Seo, Jeongkuk, et al.
Publicado: (2017)

The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
por: Zamò, Alberto, et al.
Publicado: (2023)

Radiotherapy in marginal zone lymphoma
por: Deinbeck, Kristin, et al.
Publicado: (2013)

Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)
por: Cho, Hyungwoo, et al.
Publicado: (2023)

Mantle cell lymphoma with features of marginal-zone lymphoma
por: Randen, Ulla, et al.
Publicado: (2011)

Marginal zone lymphomas in HIV patients
por: Genet, Philippe, et al.
Publicado: (2012)

Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma
por: Veeraballi, Sindhusha, et al.
Publicado: (2022)

Follicular lymphoma and marginal zone lymphoma: how many diseases?
por: Laurent, Camille, et al.
Publicado: (2022)

Development of Organ-Preserving Radiation Therapy in Gastric Marginal Zone Lymphoma
por: Rolf, Daniel, et al.
Publicado: (2022)

Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)
por: Yoon, Dok Hyun, et al.
Publicado: (2016)

Primary extranodal marginal zone lymphoma – Epididymis
por: Rajaian, Shanmugasundaram, et al.
Publicado: (2011)

The genetic landscape of dural marginal zone lymphomas
por: Ganapathi, Karthik A., et al.
Publicado: (2016)

Unusual Course of Splenic Marginal Zone Lymphoma
por: Tun, Nay T., et al.
Publicado: (2013)

The Biology of Ocular Adnexal Marginal Zone Lymphomas
por: Johansson, Patricia, et al.
Publicado: (2022)

Deregulation of cellular signaling in marginal zone lymphoma
por: Du, Ming-Qing
Publicado: (2018)

Retrospective characterization of nodal marginal zone lymphoma
por: Stuver, Robert, et al.
Publicado: (2023)

Marginal zone lymphoma expression of histidine‐rich glycoprotein correlates with improved survival
por: Persson Skare, Tor, et al.
Publicado: (2020)

Postibrutinib relapse outcomes for patients with marginal zone lymphoma
por: Epperla, Narendranath, et al.
Publicado: (2022)

Mutational analysis of extranodal marginal zone lymphoma using next generation sequencing
por: Huh, Seok Jae, et al.
Publicado: (2020)

Follicular lymphoma presenting like marginal zone lymphoma: A case report
por: Peng, Hao-Yu, et al.
Publicado: (2022)

Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL)
por: Kim, Kyoung Ha, et al.
Publicado: (2023)

Clinical features and survival outcomes of patients with lymphoplasmacytic lymphoma, including non-IgM type, in Korea: a single-center experience
por: Kang, Jihoon, et al.
Publicado: (2018)

Gastric Marginal Zone B Cell Lymphoma of the Duodenum
por: Ndzengue, A., et al.
Publicado: (2011)

Karyometric Comparison of Splenic and Gastric Marginal Zone Lymphomas
por: Styczeń, Magdalena, et al.
Publicado: (2012)

Marginal Zone Lymphoma Complicated by Protein Losing Enteropathy
por: Stanek, Nadine, et al.
Publicado: (2016)

Spontaneous splenic rupture due to marginal zone lymphoma
por: Yepuri, Natesh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9019rj0s798bqvu7gq2bloum8v